Patents by Inventor Karen Bannister

Karen Bannister has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS FOR TREATMENT OF DISORDERS
    Publication number: 20210261655
    Abstract: The invention relates to stable and non-aggregating compositions comprising an IL-17A binding molecule, in particular a single domain antibody. Such compositions are useful for topical administration in the treatment of disease, for example skin disease or asthma.
    Type: Application
    Filed: February 5, 2021
    Publication date: August 26, 2021
    Inventors: Karen Bannister, Ulla Lashmar, Daniel Pettit, Thomas Sandal
  • Composition for treatment of disorders
    Patent number: 10947308
    Abstract: The invention relates to stable and non-aggregating compositions comprising an IL-17A binding molecule, in particular a single domain antibody. Such compositions are useful for topical administration in the treatment of disease, for example skin disease or asthma.
    Type: Grant
    Filed: July 10, 2017
    Date of Patent: March 16, 2021
    Assignee: Crescendo Biologics Limited
    Inventors: Karen Bannister, Ulla Lashmar, Daniel Pettit, Thomas Sandal
  • Composition for Treatment of Disorders
    Publication number: 20190300603
    Abstract: The invention relates to stable and non-aggregating compositions comprising an IL-17A binding molecule, in particular a single domain antibody. Such compositions are useful for topical administration in the treatment of disease, for example skin disease or asthma.
    Type: Application
    Filed: July 10, 2017
    Publication date: October 3, 2019
    Inventors: Karen Bannister, Ulla Lashmar, Daniel Pettit, Thomas Sandal
  • Anti-interleukin-13 antibody compositions
    Patent number: 10358488
    Abstract: The invention relates to a pharmaceutical composition comprising an interleukin-13 antibody, more particularly a monoclonal interleukin-13 antibody, especially a human interleukin-13 monoclonal antibody, to a process for purifying said antibody and to the use of said composition in treating interleukin-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, chronic obstructive pulmonary disease, scleroderma, inflammatory bowel disease and Hodgkin's lymphoma, particularly asthma.
    Type: Grant
    Filed: July 14, 2015
    Date of Patent: July 23, 2019
    Assignee: MEDIMMUNE LIMITED
    Inventors: Claire Louise Hope, Karen Bannister, Brendan Cormick Fish, Jeanette Elizabeth Langstone
  • METHODS OF PURIFYING ANTI-INTERLEUKIN-13 ANTIBODIES
    Publication number: 20160002327
    Abstract: The invention relates to a pharmaceutical composition comprising an interleukin-13 antibody, more particularly a monoclonal interleukin-13 antibody, especially a human interleukin-13 monoclonal antibody, to a process for purifying said antibody and to the use of said composition in treating interleukin-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, chronic obstructive pulmonary disease, scleroderma, inflammatory bowel disease and Hodgkin's lymphoma, particularly asthma.
    Type: Application
    Filed: July 14, 2015
    Publication date: January 7, 2016
    Inventors: Claire Louise Hope, Karen Bannister, Brendan Cormick Fish, Jeanette Elizabeth Langstone
  • Methods of purifying anti-interleukin-13 antibodies
    Patent number: 9107945
    Abstract: The invention relates to a pharmaceutical composition comprising an interleukin-13 antibody, more particularly a monoclonal interleukin-13 antibody, especially a human interleukin-13 monoclonal antibody, to a process for purifying said antibody and to the use of said composition in treating interleukin-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, chronic obstructive pulmonary disease, scleroderma, inflammatory bowel disease and Hodgkin's lymphoma, particularly asthma.
    Type: Grant
    Filed: December 13, 2010
    Date of Patent: August 18, 2015
    Assignee: MedImmune Limited
    Inventors: Claire Louise Hope, Karen Bannister, Brendan Cormick Fish, Jeanette Elizabeth Langstone
  • Interleukin-13 Antibody Composition
    Publication number: 20110086038
    Abstract: The invention relates to a pharmaceutical composition comprising an interleukin-13 antibody, more particularly a monoclonal interleukin-13 antibody, especially a human interleukin-13 monoclonal antibody, to a process for purifying said antibody and to the use of said composition in treating interleukin-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, chronic obstructive pulmonary disease, scleroderma, inflammatory bowel disease and Hodgkin's lymphoma, particularly asthma.
    Type: Application
    Filed: December 13, 2010
    Publication date: April 14, 2011
    Applicant: Medlmmune Limited
    Inventors: Claire Louise Hope, Karen Bannister, Brendan Cormack Fish, Jeanette Elizabeth Langstone
  • Interleukin-13 Antibody Composition
    Publication number: 20080248048
    Abstract: The invention relates to a pharmaceutical composition comprising an interleukin-13 antibody, more particularly a monoclonal interleukin-13 antibody, especially a human interleukin-13 monoclonal antibody, to a process for purifying said antibody and to the use of said composition in treating interleukin-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, chronic obstructive pulmonary disease, scleroderma, inflammatory bowel disease and Hodgkin's lymphoma, particularly asthma.
    Type: Application
    Filed: September 29, 2006
    Publication date: October 9, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Brendan Cormick Fish, Jeanette Elizabeth Langstone, Karen Bannister, Claire Louise Hope
  • Comfort earring clip
    Patent number: 4796443
    Abstract: A support device for an earring which includes a back support. A back ear clamping member carried by the back support is adjustable to a forward and rearward position with respect to a front ear clamping member. The back ear clamping member is free to move limitedly in both a horizontal and vertical direction when either in forward or rearward adjusted position, but when in an intermediate position is substantially restrained from movement.
    Type: Grant
    Filed: February 2, 1987
    Date of Patent: January 10, 1989
    Assignee: Trifari, Krussman & Fishel, Inc.
    Inventors: A. Karen Bannister, Kristen Brandriff, John A. Carlotto, Richard J. DiDonato, Virginia Haigh, Edmond Sirois